METASTATIC COLORECTAL CANCER WITH RAS MUTATION

Clinical trials for METASTATIC COLORECTAL CANCER WITH RAS MUTATION explained in plain language.

Never miss a new study

Get alerted when new METASTATIC COLORECTAL CANCER WITH RAS MUTATION trials appear

Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER WITH RAS MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat colon cancer: experimental drug combo enters human testing

Disease control ENROLLING_BY_INVITATION

This study is testing whether adding an experimental drug called XS-03 to standard chemotherapy combinations helps control metastatic colorectal cancer that has a specific genetic change called a RAS mutation. The trial will first find the safest dose of XS-03, then see if the ne…

Matched conditions: METASTATIC COLORECTAL CANCER WITH RAS MUTATION

Phase: PHASE1, PHASE2 • Sponsor: NovaOnco Therapeutics Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

METASTATIC COLORECTAL CANCER WITH RAS MUTATION

Get alerted when new METASTATIC COLORECTAL CANCER WITH RAS MUTATION trials appear

New hope for Tough-to-Treat colon cancer: experimental drug combo enters human testing